A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B
ConditionEssential Hypertension
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age19+
SponsorAddpharma Inc.
About this trial
The purpose of this study is to evaluate the efficacy and safety of co-administration of AD-227A and AD-227B in patients with essential hypertension
Eligibility criteria
Qualifiers
Signed informed consent
Patients with Essential Hypertension
Other inclusions applied
Disqualifiers
Patient with Secondary Hypertension
Other exclusions applied
Trial design
Treatments tested in this trial
- AD-227A
- AD-227B
- AD-227C
- Placebo of AD-227B
- Placebo of AD-227C
Treatment groups
251 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov